SCHEMBL22365374

SCHEMBL22365374

CC(Cc1cccc(OCC2CC2c2ccccc2)c1)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 18/20 0.61
▸ SCN3A Q9NY46 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22365327 0.91 FFAR1 (0.64) FFAR1
SCHEMBL22365404 0.90 FFAR1 (0.56) FFAR1SCN3A
SCHEMBL22365322 0.85 FFAR1 (0.64) FFAR1
SCHEMBL22365246 0.84 FFAR1 (0.61) FFAR1
SCHEMBL22365347 0.82 FFAR1 (0.58) FFAR1SCN3A
SCHEMBL22365318 0.81 ACACA (0.49) FFAR1
SCHEMBL22365470 0.78 FFAR1 (0.64) FFAR1
SCHEMBL22365310 0.78 FFAR1 (0.66) FFAR1
SCHEMBL20905595 0.78 MME (0.59) FFAR1
SCHEMBL16993561 0.76 FFAR1 (1.00) FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3102198-B1 ANTIDIABETIC COMPOUNDS MERCK SHARP & DOHME (US) 2020-08-26 — — EP disclosed
Send feedback